Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment With Atezolizumab
NCT06771518
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Small Cell Lung Cancer
Interventions
RADIATION:
Thoracic radiotherapy
DRUG:
Atezolizumab 1200 mg e.v. q21
Sponsor
Regina Elena Cancer Institute